Recruitment

Eingeschlossene Patienten: 24.086 (Stand 02. April 2026)
Amgevita® (Adalimumab)278
Avtozma® (Tocilizumab)1
Benepali® (Etanercept)1344
Cimzia® (Certolizumab)1070
Enbrel® (Etanercept)2882
Erelzi® (Etanercept)647
Flixabi® (Infliximab)10
Hukyndra® (Adalimumab)27
Hulio® (Adalimumab)330
Humira® (Adalimumab)2912
Hyrimoz® (Adalimumab)310
Idacio® (Adalimumab)77
Imraldi® (Adalimumab)264
Inflectra™ (Infliximab)16
Jyseleca® (Filgotinib)211
Kevzara® (Sarilumab)251
Kineret® (Anakinra)89
MabThera® (Rituximab)1459
Nepexto® (Etanercept)131
Olumiant® (Baricitinib)570
Orencia® (Abatacept)1003
Remicade® (Infliximab)762
Remsima® (Infliximab)27
Rinvoq® (Upadacitinib)375
Rixathon® (Rituximab)20
RoActemra® (Tocilizumab)1385
Ruxience® (Rituximab)1
Simponi® (Golimumab)486
Truxima® (Rituximab)9
Tyenne® (Tocilizumab)84
Xeljanz® (Tofacitinib)406
Yuflyma® (Adalimumab)93
Zessly® (Infliximab)2
Kontrollen6554